Semax
Also known as: ACTH(4-10) analog
Heptapeptide derived from ACTH(4-10). Russian neuropeptide studied for nootropic and neuroprotective effects, partly via BDNF upregulation.
Mostly preclinical neuroprotection evidence
Semax has preclinical neuroprotection literature and regional clinical history, but limited independently validated human evidence for consumer cognitive use.
Mostly animal, ex vivo, cell, or indirect evidence.
Evidence basis
- Animal neuroprotection models
- Regional clinical history
- Limited independent human evidence
Key references
How to read this entry
Dose references and half-life values are pulled from trial protocols, labels, reviews, or published summaries where available. They are context for research and comparison, not a personal dosing recommendation.
Status matters: approved drugs have regulated indications; investigational compounds are still being studied; research-only peptides do not have established human dosing, safety, or efficacy for consumer use.
Compare with related peptides
Stay inside the same research category and compare mechanism, status and evidence quality.
Category hub
Open the category page for the full comparison table and FAQ.